Aiello Allison E, Larson Elaine L, Levy Stuart B
Department of Epidemiology and Center for Social Epidemiology and Population Health, University of Michigan, Ann Arbor, Ann Arbor, MI 48104-2548, USA.
Clin Infect Dis. 2007 Sep 1;45 Suppl 2:S137-47. doi: 10.1086/519255.
Much has been written recently about the potential hazards versus benefits of antibacterial (biocide)-containing soaps. The purpose of this systematic literature review was to assess the studies that have examined the efficacy of products containing triclosan, compared with that of plain soap, in the community setting, as well as to evaluate findings that address potential hazards of this use--namely, the emergence of antibiotic-resistant bacteria.
The PubMed database was searched for English-language articles, using relevant keyword combinations for articles published between 1980 and 2006. Twenty-seven studies were eventually identified as being relevant to the review.
Soaps containing triclosan within the range of concentrations commonly used in the community setting (0.1%-0.45% wt/vol) were no more effective than plain soap at preventing infectious illness symptoms and reducing bacterial levels on the hands. Several laboratory studies demonstrated evidence of triclosan-adapted cross-resistance to antibiotics among different species of bacteria.
The lack of an additional health benefit associated with the use of triclosan-containing consumer soaps over regular soap, coupled with laboratory data demonstrating a potential risk of selecting for drug resistance, warrants further evaluation by governmental regulators regarding antibacterial product claims and advertising. Further studies of this issue are encouraged.
最近有很多关于含抗菌(杀生剂)肥皂的潜在危害与益处的论述。本系统文献综述的目的是评估在社区环境中,将含三氯生的产品与普通肥皂的功效进行对比的研究,同时评估涉及这种使用方式潜在危害(即抗生素耐药菌的出现)的研究结果。
在PubMed数据库中搜索1980年至2006年间发表的英文文章,使用相关关键词组合。最终确定了27项与该综述相关的研究。
在社区环境中常用的浓度范围内(0.1%-0.45%重量/体积)含三氯生的肥皂,在预防传染病症状和降低手部细菌水平方面并不比普通肥皂更有效。几项实验室研究证明了不同细菌物种之间对三氯生适应性的抗生素交叉耐药性的证据。
与普通肥皂相比,使用含三氯生的消费用肥皂并未带来额外的健康益处,再加上实验室数据表明存在选择耐药性的潜在风险,这值得政府监管机构对抗菌产品的声明和广告进行进一步评估。鼓励对此问题进行进一步研究。